PURE Bioscience Inc. develops and markets technology-based bioscience products to address numerous health challenges, including Staph (MRSA). The company’s proprietary high efficacy/low toxicity bioscience technologies cater to the consumer use of “green” products while maintaining efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver, which formulates well with other compounds. For more information visit the company’s Web site at: www.purebio.com.

Aegis Capital Corp. is a full service retail and institutional broker-dealer located in New York City. Aegis Capital’s management is committed to providing the highest level of service to its clients. The firm realizes this goal by running an independent, conflict-free platform that is focused on enhancing the goals of clients by bringing unencumbered advice, which enables them to freely create a plan centered on each client. For more information on Aegis Capital, visit www.aegiscapcorp.com.

Let us hear your thoughts below: